Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy

European Journal of Ophthalmology

Volumn 19, Issue 1, 2009, Pages 154-158

  Reibaldi, Michele ^a   Boscia, F ^b   Avitabile, T ^a   Russo, A ^a   Cannemi, V ^a   Uva, M G ^a   Reibaldi, A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Chronic central serous chorioretinopathy; Fluence; Photodynamic therapy

Indexed keywords

INDOCYANINE GREEN;

ADULT; ARTICLE; BIOMICROSCOPY; CASE REPORT; CENTRAL SEROUS RETINOPATHY; CHRONIC PATIENT; COMORBIDITY; FLUORESCENCE ANGIOGRAPHY; HUMAN; LOW FLUENCE PHOTODYNAMIC THERAPY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; PERIMETRY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA ANGIOGRAPHY; RETINA DETACHMENT; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY;

ATROPHY; CHRONIC DISEASE; COLORING AGENTS; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; SERUM; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 69249109729     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900126     Document Type: Article

References (8)

1. Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol 2008; 86: 126-45.
2. Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003; 23: 1-7.
3. Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol 2005; 123: 448-57.
4. Michels S, Hansmann F, Geitzenauer W, Schmidt-Erfurth U. Influence of treatment parameters on selectivity of verteporfin therapy. Invest Ophthalmol Vis Sci 2006; 47: 371-6.
5. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003; 23: 752-63.
6. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003; 87: 1453-8.
7. Yannuzzi LA, Slakter JS, Gross NE. Indocyanine green angiography guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003; 23: 288-98.
8. Piccolino FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 2005; 139: 87-99.